Novel Treatments for Breast Cancer With Samira Syed, MD
Kristin Wright, PharmD
Expert Analysis
Dr. Samira Syed, MD, is an Associate Professor of Internal Medicine at UT Southwestern Simmons Comprehensive Cancer Center, where she treats patients and focuses on breast cancer research. In this interview, Dr. Syed discusses recent therapeutic advances and future directions in the treatment of patients with breast cancer. This interview has ...
Genetic Testing for Patients With Breast Cancer: Jacqueline Mersch, Genetic Counselor
Kristin Wright, PharmD
Expert Analysis
This interview has been conducted in partnership with the National Breast Cancer Foundation (NBCF). Recognized as one of the leading breast cancer organizations in the world, NBCF is Helping Women Now® by providing early detection, education, and support services to those affected by breast cancer. A recipient of Charity Navigator's highest 4-star ...
Managing the Care of Patients With Renal Cell Carcinoma During the COVID-19 Pandemic: Advice from Nazy Zomorodian, RNC, MSN, CUNP, CCRC
Sarah Williams, MAT
Expert Analysis
Nazy Zomorodian, RNC, MSN, CUNP, CCRC. At the Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit in Los Angeles, California, Oncology Data Advisor spoke with Nazy Zomorodian, NP, a nurse practitioner in the Department of Urology at the University of California Los Angeles (UCLA) Medical Center, about strategies for optimizing patient experiences during renal cell carcinoma treatment. Ms. Zomorodian discusses the challenges of treating patients with renal cell carcinoma, particularly during the COVID-19 pandemic, and shares strategies for promoting adherence and optimizing treatment outcomes.
Navigating Cancer Genetic Risk Factors and Common Questions about Breast Cancer With Kathy Pratt, BSN, RN, OCN®, CBCN®, ONN-CG
Elizabeth Heller, PhD
Expert Analysis
Kathy Pratt, BSN, RN, OCN®, CBCN®, ONN-CG To celebrate Breast Cancer Awareness Month, Kathy Pratt, BSN, RN, OCN®, CBCN®, ONN-CG, a genetic patient navigator at UT Southwestern Simmons Comprehensive Cancer Center, discusses her role in reaching out to patients identified to have a greatly increased risk of developing cancer in their lifetimes. In this interview, she shares her advice in helping individuals prevent cancer, as well as her answers to her patients' common questions about breast cancer.
Breast Cancer Genetic Risk and Evaluation With Lillie Shockney, RN, BS, MAS, HON-ONN-CG
Keira Smith
Expert Analysis
Lillie Shockney, RN, BS, MAS, HON-ONN-CG. In honor of Breast Cancer Awareness Month, Lillie Shockney RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and a member of the National Breast Cancer Foundation (NBCF) Medical Advisory Council, discusses the genetic factors that come into play in the development of breast cancer. In addition, she shares advice for which individuals should receive genetic testing and when, as well as strategies for counseling individuals who are undergoing genetic testing.
Breast Cancer Risk Factors and Prevention With Lillie Shockney, RN, BS, MAS, HON-ONN-CG
Keira Smith
Expert Analysis
Lillie Shockney, RN, BS, MAS, HON-ONN-CG.  In honor of Breast Cancer Awareness Month, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and a member of the National Breast Cancer Foundation (NBCF) Medical Advisory Council, discusses factors in the risk and prevention of breast cancer. Ms. Shockney shares advice for minimizing one's risk of developing breast cancer and explains the genetic factors that can come into play in the development of this disease.
World Cancer Research Day With Dr. Thomas Abrams
Keira Smith
Expert Analysis
Oncology Data Advisor™ · World Cancer Research Day With Dr. Thomas Abrams On World Cancer Research Day, Dr. Thomas Abrams of Harvard Medical School discussed his career as a gastrointestinal cancer researcher and the progress that has been made in this field.
Perspectives on Metastatic and Castration-Resistant Prostate Cancer: A Discussion with Ulka Vaishampayan, MD
Selma Khenissi, MPS
Expert Analysis
Selma Khenissi, MPS: Hello, welcome to Oncology Data Advisor. I'm Selma Khenissi from i3 Health. In honor of prostate cancer awareness month, we are here today with Dr. Ulka Vaishampayan, who will be discussing issues surrounding prostate cancer. Welcome. Ulka Vaishampayan, MD: Thank you for having me on this interview. I would like to bring our pr...
Improving Patient Experiences in Multiple Myeloma With Tiffany Richards, PhD, ANP-BC
Sarah Williams, MAT
Expert Analysis
At the Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit in Los Angeles, California, Oncology Data Advisor spoke with Tiffany Richards, PhD, ANP-BC, Advanced Practice Nurse at MD Anderson Cancer Center, about strategies for optimizing patient experiences during multiple myeloma treatment. Dr. Richards discusses the challeng...
World Cancer Research Day With Dr. Thomas Abrams
Keira Smith
Expert Analysis
Thomas Abrams, MD. On World Cancer Research Day, Dr. Thomas Abrams, Assistant Professor of Medicine at Harvard Medical School and the new Editor in Chief of Oncology Data Advisor, discusses his career as a gastrointestinal cancer researcher, the recent advancements that have been made, and the progress that is on the horizon in this field. 
Optimizing Treatment Planning for Immune Thrombocytopenia: A Conversation With Allison Imahiyerobo, APN
Keira Smith
Expert Analysis
· In this podcast, Allison Imahiyerobo, APN, of Hematology Oncology Physicians of Englewood, shares strategies on how to optimize treatment planning for patients with immune thrombocytopenia (ITP).  
Recent Advances in T-Cell Lymphoma: A Conversation with Dr. Steven Horwitz
Keira Smith
Expert Analysis
· In this podcast, Dr. Steven Horwitz of  Memorial Sloan Kettering Cancer Center discusses recent progress in the treatment and management of T-cell lymphoma. Listen now to hear more!
Improving the Management of Metastatic Breast Cancer: A Conversation With Dr. Sara Tolaney
Keira Smith
Podcast
· Keira Smith: Welcome to Oncology Data AdvisorTM, where we explore the latest advances in cancer research and treatment. I'm Keira Smith. In this podcast, Dr. Sara Tolaney from Dana-Farber Cancer Institute will be discussing strategies for improving the management of patients with metastatic breast cancer. Thank you for joining us, Dr. Tola...
Optimizing Treatment Planning for Immune Thrombocytopenia: A Video Interview With Allison Imahiyerobo, APN
Keira Smith
Expert Analysis
Keira Smith: Hi. I'm Keira Smith from Oncology Data Advisor. I'm here today with Allison Imahiyerobo. Allison Imahiyerobo: Hi Keira, my name is Alli Imahiyerobo. I'm a nurse practitioner, and I practice at Hematology Oncology Physicians of Englewood in New Jersey. I focus on both benign and malignant hematology. Keira Smith: What are some of the mo...
The Promising Effects of Patient-Reported Symptom Data on Survival and Well-Being: A Conversation With Dr. Kelly Brassil
Selma Khenissi, MPS
Podcast
Welcome to Oncology Data Advisor, where we explore the latest advances in cancer research and treatment. I am Selma Khenissi from i3 Health. In this podcast, Dr. Kelly Brassil, PhD, RN, from The University of Texas MD Anderson Cancer Center, will be discussing patient-reported symptom data and how it affects patient survival and quality of life. Se...
Recent Advances in T-Cell Lymphoma: A Video Interview With Dr. Steven Horwitz
Keira Smith
Expert Analysis
In this interview, Steven Horwitz, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, speaks with Oncology Data Advisor about the recent advancements in the treatment of T-cell lymphoma. Keira Smith: Hi, I'm Keira Smith from Oncology Data AdvisorTM. I'm here today with Dr. Steven Horwitz. Steven Horwitz, MD: Hi, pleasure ...
Improving the Management of Metastatic Breast Cancer: A Conversation With Dr. Sara Tolaney
Keira Smith
Expert Analysis
Keira Smith: Hi, I'm Keira Smith from Oncology Data AdvisorTM. I'm here today with Dr. Sara Tolaney. Sara Tolaney, MD, MPH: Thanks so much for having me. I'm Sara Tolaney. I'm a breast medical oncologist at Dana-Farber Cancer Institute here in Boston. Keira Smith: Thank you so much for joining us, Dr. Tolaney. So what are some of the most challengi...
Understanding Soft Tissue Sarcoma: Vicki L. Keedy, MD, MSCI, and Brian P. Rubin, MD, PhD
Selma Khenissi, MPS
Expert Analysis
Soft tissue sarcoma is a rare cancer, estimated to be 0.7% of all new cancer cases in 2021. In this excerpt of the transcript from their continuing medical education/nursing continuing professional development (CME/NCPD)-approved activity, Virtual Tumor Board: Optimizing Personalized Care Plans for Patients with Advanced Soft Tissue Sarcoma, V...
The Promising Effects of Patient-Reported Symptom Data on Survival and Well-Being: A Conversation With Dr. Kelly Brassil
Selma Khenissi, MPS
Expert Analysis
  Selma Khenissi, MPS: Hello. Welcome to Oncology Data Advisor, your leading source for oncology news. I am Selma Khenissi from i3 Health. We are here today with Dr. Kelly Brassil, PhD, RN, Advanced Practice Nurse at the University of Texas MD Anderson Cancer Center. She'll be discussing patient-reported symptom data and its positive effect on...
Challenges and New Developments in Metastatic Colorectal Cancer With Tanios Bekaii-Saab, MD
Keira Smith
Expert Analysis
Despite the many obstacles associated with treating and managing patients with metastatic colorectal cancer, the ongoing study of several novel agents has the potential to significantly improve the outcomes of these patients in the coming years. In this interview, Tanios Bekaii-Saab, MD, Professor of Medicine at the Mayo Clinic Cancer Center in Pho...

Copyright © 2022 Oncology Data Advisor. All rights reserved.